Retinal Implant Market Size Worth $74.7 Million by 2026 | CAGR 10.6%: Grand View Research, Inc.
SAN FRANCISCO, May 14, 2019 /PRNewswire/ - The global retinal implant market size is expected to reach USD 74.7 million by 2026, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 10.6% over the forecast period. Increasing prevalence of target diseases, and rising geriatric population are the key driving factors for the market. Rising capability of restoring vision is anticipated to bode well for demand over the forecast period.
Key suggestions from the report:
- In terms of revenue, implantable miniature telescope segment is projected to expand at the highest CAGR over the forecast period. Increasing prevalence of AMD among geriatric population and usage of implantable devices to treat vision problems might drive the segment's growth over the forecast period
- In 2026, Asia-Pacific market is expected to witness the fastest CAGR over the forecast period owing to increasing geriatric population and disposable income
- VisionCare, Inc.; Retina Implant AG; and Second Sight Medical Products, Inc. are expected to dominate the retinal implant market over the forecast period.
Read 59 page research report with TOC on "Retinal Implant Market Size, Share & Trends Analysis Report By Device Type (Retina Implant Alpha AMS, Implantable Miniature Telescope, and Argus II), By Region, And Segment Forecasts, 2018 - 2026" at: https://www.grandviewresearch.com/industry-analysis/retinal-implant-market
Laser therapy and Photodynamic Therapy (PTD) and some of the conventional treatments available for Retinitis Pigmentosa (RP) and Age-Related Macular Degeneration (AMD). Drugs such as Lucentis, Macugen, Eylea, and Vitamin A are a part of therapeutic treatment. Such treatments aid in reducing disease progression and thereby, delaying blindness. However, none of these treatments can completely cure the disease and restore vision. As a result, treatment procedures that restore vision are highly in demand.
Currently approved devices are capable of restoring vision with the help of electrodes, camera chips, lenses, software, and other tools. Moreover, implantable miniature telescope, Argus II is easy to use and enables patients to carry out their daily activities with ease. Furthermore, these devices can be used for a prolonged period of time, eliminating the need for another surgery. Therefore, the capability of advanced implantable devices to restore vision is expected to propel the market growth in near future.
Increasing geriatric population and rising disposable income in developing economies such as Japan, China, and India are also expected to boost the retinal implant market over the forecast period. Moreover, increasing healthcare expenditure by governments and private sectors and initiatives by major market players to operate in untapped regions are also anticipated to propel the growth in the forthcoming years.
Grand View Research has segmented the global retinal implant market on the basis of device type and region:
- Retinal Implant Device Type Outlook (Revenue USD Million; 2014 - 2026)
- Retina Implant Alpha AMS
- Implantable Miniature Telescope
- Argus II
- Others
- Antinuclear Antibody Test Technique Outlook (Revenue, USD Million, 2014 - 2025)
- ELISA
- Immunofluorescence Assay
- Multiplex Assay
- Retinal Implant Regional Outlook (Revenue, USD Million; 2014 - 2026)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia Pacific
- China
- Japan
- Latin America
- Brazil
- MEA
- Saudi Arabia
Find more research reports on Medical Devices Industry, by Grand View Research:
- Temperature Management Market – Rising ageing population along with increased incidences of cardiac arrest as well as central nervous systems disorders is expected to drive the global temperature management market growth.
- Oncology Devices Market – Oncology devices market is expected to grow during the forecast period owing to the increasing prevalence of cancer globally and healthcare expenditure level of the patients.
- IV Therapy and Vein Access Devices Market – The prevalence of diabetes, increasing rates of road accidents and increasing number of surgical procedures is expected to drive the intravenous therapy and vein access devices market in coming six years.
Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Share this article